Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001–2012 See the full article here. Background. Hepatocellular carcinoma (HCC) is a complication of chronic hepatitis B and C virus (HBV and HCV) inf...
Advocacy
Governor Andrew M. Cuomo today announced the nation's first strategy to eliminate hepatitis C, including the establishment of a Hepatitis C Elimination Task Force that will advise the state as it implements its plan going forward.
The NYC Department of Health and Mental Hygiene (DOHMH) examined anti-HCV and RNA testing performed by dialysis centres in NYC between 1 January 2014 and 31 December 2017 to assess HCV testing practices.
Evaluation of whether enrollment in Project INSPIRE was associated with differences in HCV treatment and cure compared with a demographically similar group not enrolled in the programme.
Project INSPIRE provides care coordination to HCV patients and a web‐based training program (telementoring) on disease management and treatment by HCV specialists to primary care providers inexperienced in HCV treatment.
SAVE THE DATE! Wednesday, July 25th is the 6th Annual National African American Hepatitis C Action Day (NAAHCAD). This day provides an opportunity to promote Hepatitis C prevention, testing, and treatment messages to public health partners and the black community. NAAHCAD also pr...
The new effort aims to stop the Hepatitis C virus in its tracks by increasing access to medications that can cure Hepatitis C and expanding programs to connect New Yorkers in high-risk communities with wrap-around Hepatitis C prevention, screenings and treatment services.
In 2014, NYC Council established the Viral Hepatitis Initiative, which has served to establish and sustain four programs to build community health organization capacity to prevent, identify, manage and treat hepatitis B and C.
Sign on to a letter urging Congressional leaders to allocate opioid funding to CDC’s viral hepatitis program in FY2018.
The primary goals of the Manual are to increase advocates' knowledge about available HCV tests and treatments and to jumpstart discussions on advocacy strategies that can be used to open up affordable access for more people with HCV.
